Kerri M. Smith

597 total citations
18 papers, 488 citations indexed

About

Kerri M. Smith is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Kerri M. Smith has authored 18 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Molecular Medicine and 4 papers in Pharmacology. Recurrent topics in Kerri M. Smith's work include Antibiotic Resistance in Bacteria (6 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Analytical Chemistry and Chromatography (3 papers). Kerri M. Smith is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Analytical Chemistry and Chromatography (3 papers). Kerri M. Smith collaborates with scholars based in United States, United Kingdom and Singapore. Kerri M. Smith's co-authors include Yan Xu, Robert A. Bonomo, Magdalena A. Taracila, Krisztina M. Papp‐Wallace, Yan Xu, Andrea M. Hujer, Marisa Winkler, Paul Rainville, Ian D. Wilson and Christopher R. Bethel and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Analytical Chemistry.

In The Last Decade

Kerri M. Smith

18 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerri M. Smith United States 13 214 199 123 64 59 18 488
Nandini Sharma United States 10 230 1.1× 201 1.0× 95 0.8× 65 1.0× 9 0.2× 19 531
Zishuo Cheng United States 17 293 1.4× 507 2.5× 197 1.6× 152 2.4× 29 0.5× 29 820
Tricia L. May‐Dracka United States 7 206 1.0× 143 0.7× 105 0.9× 42 0.7× 7 0.1× 7 451
Martijn Zwama Japan 8 276 1.3× 274 1.4× 96 0.8× 60 0.9× 6 0.1× 11 600
Emmanuelle Steinfels France 8 315 1.5× 124 0.6× 70 0.6× 35 0.5× 19 0.3× 8 618
C. Tesar United States 10 221 1.0× 184 0.9× 76 0.6× 44 0.7× 4 0.1× 13 467
Masami Ohtsuka Japan 17 325 1.5× 289 1.5× 209 1.7× 112 1.8× 14 0.2× 27 945
Raymond T. Testa United States 15 242 1.1× 453 2.3× 432 3.5× 131 2.0× 14 0.2× 25 801
Bernardo Ribeiro da Cunha Portugal 9 162 0.8× 70 0.4× 64 0.5× 17 0.3× 12 0.2× 14 383
Dinakara Rao Ampasala India 16 357 1.7× 100 0.5× 110 0.9× 23 0.4× 5 0.1× 42 683

Countries citing papers authored by Kerri M. Smith

Since Specialization
Citations

This map shows the geographic impact of Kerri M. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerri M. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerri M. Smith more than expected).

Fields of papers citing papers by Kerri M. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerri M. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerri M. Smith. The network helps show where Kerri M. Smith may publish in the future.

Co-authorship network of co-authors of Kerri M. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Kerri M. Smith. A scholar is included among the top collaborators of Kerri M. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerri M. Smith. Kerri M. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gritti, Fabrice & Kerri M. Smith. (2023). Harmonization of Experimental Methods Used to Measure the True Hold-Up Volume of Liquid Chromatography Columns. LCGC North America. 28–33. 10 indexed citations
2.
Virgiliou, Christina, Thomas H. Walter, Kerri M. Smith, et al.. (2022). Application of a hybrid zwitterionic hydrophilic interaction liquid chromatography column in metabolic profiling studies. Journal of Chromatography A. 1672. 463013–463013. 18 indexed citations
3.
Smith, Kerri M., Ian D. Wilson, & Paul Rainville. (2020). Sensitive and Reproducible Mass Spectrometry-Compatible RP-UHPLC Analysis of Tricarboxylic Acid Cycle and Related Metabolites in Biological Fluids: Application to Human Urine. Analytical Chemistry. 93(2). 1009–1015. 25 indexed citations
5.
Wang, Yan‐Hong, Mei Wang, Bharathi Avula, et al.. (2019). The Chemical Characterization of Eleutherococcus senticosus and Ci-wu-jia Tea Using UHPLC-UV-QTOF/MS. International Journal of Molecular Sciences. 20(3). 475–475. 45 indexed citations
6.
Yuk, Jimmy, Giorgis Isaac, Kerri M. Smith, et al.. (2016). Chemical Profiling of Ginseng Species and Ginseng Herbal Products Using UPLC/QTOF-MS. Journal of the Brazilian Chemical Society. 25 indexed citations
7.
Papp‐Wallace, Krisztina M., Susana Mallo, Christopher R. Bethel, et al.. (2013). A kinetic analysis of the inhibition of FOX-4  -lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic  -lactams and carbapenems. Journal of Antimicrobial Chemotherapy. 69(3). 682–690. 19 indexed citations
8.
Kurz, Sebastian G., Kerstin Wolff, Saugata Hazra, et al.. (2013). Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of β-Lactam–β-Lactamase Inhibitor Combinations. Antimicrobial Agents and Chemotherapy. 57(12). 6085–6096. 36 indexed citations
9.
Bethel, Christopher R., Kerri M. Smith, Yan Xu, et al.. (2013). β-Lactamase Inhibition by 7-Alkylidenecephalosporin Sulfones: Allylic Transposition and Formation of an Unprecedented Stabilized Acyl-Enzyme. Journal of the American Chemical Society. 135(49). 18358–18369. 20 indexed citations
10.
Papp‐Wallace, Krisztina M., Magdalena A. Taracila, Andrea M. Hujer, et al.. (2012). Exploring the Role of a Conserved Class A Residue in the Ω-Loop of KPC-2 β-Lactamase. Journal of Biological Chemistry. 287(38). 31783–31793. 83 indexed citations
11.
Smith, Kerri M., Tianyi M. Krupka, Bryan M. Wittmann, et al.. (2012). Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene. 32(33). 3829–3839. 29 indexed citations
12.
Winkler, Marisa, Magdalena A. Taracila, Sarah M. Drawz, et al.. (2012). Design and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-Lactamase. Journal of Medicinal Chemistry. 56(3). 1084–1097. 39 indexed citations
13.
Yi, Xin, Bo Zhong, Kerri M. Smith, et al.. (2012). Identification of a Class of Novel Tubulin Inhibitors. Journal of Medicinal Chemistry. 55(7). 3425–3435. 28 indexed citations
14.
Smith, Kerri M. & Yan Xu. (2012). Tissue Sample Preparation in Bioanalytical Assays. Bioanalysis. 4(6). 741–749. 31 indexed citations
15.
Papp‐Wallace, Krisztina M., Magdalena A. Taracila, Kerri M. Smith, Yan Xu, & Robert A. Bonomo. (2012). Understanding the Molecular Determinants of Substrate and Inhibitor Specificities in the Carbapenemase KPC-2: Exploring the Roles of Arg220 and Glu276. Antimicrobial Agents and Chemotherapy. 56(8). 4428–4438. 47 indexed citations
16.
Smith, Kerri M., et al.. (2011). Design and synthesis of a biotinylated probe of COX-2 inhibitor nimesulide analog JCC76. Bioorganic & Medicinal Chemistry Letters. 21(18). 5324–5327. 11 indexed citations
17.
Smith, Kerri M., et al.. (2011). Determination of hexamethylene bisacetamide, an antineoplastic compound, in mouse and human plasma by LC–MS/MS. Journal of Chromatography B. 879(23). 2206–2212. 6 indexed citations
18.
Newton, K. G., J. Harrison, & Kerri M. Smith. (1977). Coliforms from hides and meat. Applied and Environmental Microbiology. 33(1). 199–200. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026